Abstract: A controlled release system includes a polymeric support, wherein the polymeric support is biodegradable; a polymeric matrix, wherein the polymeric matrix includes polyhydroalkanoate; and encapsulated gases or volatiles; and a controlled release system includes a polymeric support; a polymeric matrix, wherein the polymeric matrix includes (poly-3-hydroxybutyrate-co-3-hydroxyvalerate) and poly (?-caprolactone); and encapsulated gases or volatiles.
Type:
Grant
Filed:
July 23, 2014
Date of Patent:
October 22, 2019
Assignee:
Universidad Andrés Bello
Inventors:
Luis Velásquez, Reinaldo Campos, Danilo Gonzalez, Rubén Polanco
Abstract: An acrylic fiber for artificial hair includes an acrylic polymer, wherein the acrylic polymer includes 29.5 to 79.5% by mass of acrylonitrile, 20 to 70% by mass of vinyl chloride and/or vinylidene chloride, and 0.5 to 5% by mass of a vinyl monomer comprising a sulfonic acid group. The acrylic fiber for artificial hair includes 0.3 to 2% by mass of a good solvent for the acrylic polymer and 0.1 to 5% by mass of a compound comprising an epoxy group.
Type:
Grant
Filed:
December 21, 2017
Date of Patent:
October 8, 2019
Assignee:
KANEKA CORPORATION
Inventors:
Takeshi Tanaka, Akihiro Okamoto, Tomomichi Hashimoto, Sota Okumura
Abstract: A sprayable sunscreen cosmetic contains substantially no ultraviolet ray scattering agents which cause whiteness, and which is transparent immediately after being applied/sprayed, and that has excellent ultraviolet ray protection effect and a good sensation in use. The ultraviolet ray protection effect is not reduced, and the effects improve when in contact with water. A water-in-oil emulsified sunscreen cosmetic comprises: (A) 6 to 40 mass % of an ultraviolet ray absorbing agent; (B) an organically modified clay mineral; (C) an oil phase thickener other than the aforementioned (B); (D) a silicone-based surfactant having an HLB of less than 8; (E) a spherical resin powder; and (F) a volatile silicone oil; wherein a ratio defined as [total amount of ingredient (B) and ingredient (C)]/[total amount of (G) non-volatile liquid oils other than silicone oils] is at least 0.04 and less than 0.68.
Abstract: Disclosed herein are foaming cosmetic compositions comprising: at least one anionic thickening agent; at least two alkaline compounds; and at least one silicone. Methods for producing the foaming cosmetic compositions and for improving the stability of a foamed cosmetic composition are also disclosed.
Abstract: A shear-thinning hydrogel composition includes: a first polymer chain including: (i) a first plurality of units each having at least one of a monosaccharide and an amino acid; and (ii) a cross-linking group bound to the at least one of the monosaccharide and the amino acid of one of the first plurality of units via conversion of a carboxyl group of the unit to a peptide bond; a second polymer chain including a second plurality of the units; and a cross-linking additive connecting one of the second plurality of units to the first polymer chain via the cross-linking group.
Type:
Grant
Filed:
June 29, 2017
Date of Patent:
September 17, 2019
Assignee:
OUROTECH, INC.
Inventors:
Duleeka Nimantha Bandara Ranatunga, Andrew Christopher Wenger, Zhi Yuan (William) Lin
Abstract: Multi-functional base emulsions that can be used to form a variety of cosmetic compositions are disclosed. In one aspect, a cosmetic emulsion can include a water phase including about 10% to about 67.5% water by total weight of the cosmetic emulsion. The cosmetic emulsion can also include an oil phase that includes (a) stearalkonium hectorite, and (b) a silicone alkyl polyether selected from the group consisting of: PEG/PPG-18/18 dimethicone, PEG/PPG-20/15 dimethicone, and Lauryl PEG/PPG-18/18 dimethicone.
Type:
Grant
Filed:
December 29, 2015
Date of Patent:
September 10, 2019
Assignee:
Kimberly-Clark Worldwide, Inc.
Inventors:
Stacy A. Mundschau, YoenJung Lee, Scott W. Wenzel, Jeffery R. Seidling
Abstract: Cosmetic composition for making up and/or caring for keratin materials, in particular the skin and/or the lips, including: at least one aqueous phase gelled with at least one polymeric gelling agent that is natural or of natural origin; and at least one oily phase gelled with at least one lipophilic gelling agent chosen from particulate gelling agents, organopolysiloxane elastomers, semi-crystalline polymers and dextrin esters, and mixtures thereof; the phases forming therein a macroscopically homogeneous mixture.
Abstract: The invention relates to the use of a persistent, weatherable blend of a bird repellent and a paint coating composition on exterior surfaces such as wood or building materials, to deter birds from damaging such wood or building material. The bird repellent blend has improved weatherability while retaining the effectiveness of the bird repellent.
Type:
Grant
Filed:
June 21, 2017
Date of Patent:
September 3, 2019
Assignee:
Arkion Life Sciences, LLC
Inventors:
Kenneth E. Ballinger, Jr., Thomas A. Jerrell
Abstract: Provided is a tear lipid layer stabilizer that is capable of stabilizing a tear lipid layer and allowing the tear lipid layer to sufficiently spread over a corneal surface, to thereby prevent the evaporation of a tear aqueous layer on the corneal surface, and hence is suitable for amelioration, alleviation, or treatment of evaporative dry eye symptoms caused by Meibomian gland dysfunction, an ophthalmic solution having blended therein the tear lipid layer stabilizer, and a tear lipid layer-stabilizing method using the tear lipid layer stabilizer. The tear lipid layer stabilizer includes a copolymer that has a weight-average molecular weight of from 10,000 to 5,000,000, and contains 10 mol % to 90 mol % of a constituent unit (A) based on 2-(meth)acryloyloxyethyl phosphorylcholine and 90 mol % to 10 mol % of a constituent unit (B) based on an alkyl group-containing (meth)acrylic monomer.
Type:
Grant
Filed:
December 21, 2016
Date of Patent:
August 27, 2019
Assignee:
NOF Corporation
Inventors:
Shunsuke Sakurai, Koji Miyamoto, Yoshihisa Shimamura, Nobuyuki Yamamoto
Abstract: An aspect of the present disclosure includes a composition configured for use in the buccal cavity of a mammal and configured to adhere to the surface of a tooth or teeth and/or one or more orthodontic devices engaged to a tooth. The composition typically includes an admixed composite having an uncured (uncrosslinked) high consistency rubber base material, more typically an uncured (uncrosslinked) silicone high consistency rubber base material; a moisture activated adhesive, typically one or more polyvinylpyrrolidone; and a plasticizer, typically glycerin.
Type:
Grant
Filed:
April 28, 2017
Date of Patent:
August 27, 2019
Assignee:
ORVANCE, LLC
Inventors:
Ronald J. Schutt, Michael Edward Silver
Abstract: Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.
Type:
Grant
Filed:
June 7, 2018
Date of Patent:
August 27, 2019
Assignee:
TRICIDA, INC
Inventors:
Gerrit Klaerner, Eric F. Connor, Randi K. Gbur, Matthew J. Kade, Paul H. Kierstead, Jerry M. Buysse, Michael J. Cope, Kalpesh N. Biyani, Son H. Nguyen, Scott M. Tabakman
Abstract: The present invention provides topical dosages and formulations of lidocaine and pharmaceutically acceptable salts thereof, which are efficacious, chemically stable and physiologically balanced for safety and efficacy, particularly for debridement pain, and increase the duration of pain relief, and thereby provide more effective treatment to chronic open wounds, particularly those in non-mucosal tissue.
Abstract: An aqueous composition useful for producing capsules shells comprises a) at least one dispersed esterified cellulose ether comprising (i) groups of the formula —C(O)—R—COOA or (ii) a combination of aliphatic monovalent acyl groups and groups of the formula —C(O)—R—COOA, wherein R is a divalent aliphatic or aromatic hydrocarbon group and A is hydrogen or a cation, and b) from 0.05 to 20 percent of at least one salt of a fatty acid, based on the weight of the dispersed esterified cellulose ether, wherein the median particle size, d50, of the dispersed esterified cellulose ether particles is up to 7 micrometers, such median particle size (d50) being the size at which 50 mass percent of the particles have a smaller equivalent diameter and 50 mass percent have a larger equivalent diameter.
Type:
Grant
Filed:
March 3, 2015
Date of Patent:
August 20, 2019
Assignee:
DOW GLOBAL TECHNOLOGIES LLC
Inventors:
Neal J. Fetner, David L. Malotky, Jin Zhao, Matthias Knarr, Michael J. Devon, Roland Adden
Abstract: Provided by the present invention is a corrigent composed of a copolymer having a weight average molecular weight of 10,000-5,000,000 and comprising 10-90 mol % of a constitution unit based on 2-(meth)acryloyloxyethylphosphoryl choline, and 90-10 mol % of a (meth)acrylic monomer containing an alkyl group, a (meth)acrylic monomer containing a quaternary ammonium group and a constitution unit based on a (meth)acrylamide monomer. The present invention also provides a composition for mouth cavity containing the corrigent.
Type:
Grant
Filed:
June 30, 2016
Date of Patent:
August 13, 2019
Assignee:
NOF CORPORATION
Inventors:
Koji Miyamoto, Nobuyuki Yamamoto, Shunsuke Sakurai, Yoshihisa Shimamura
Abstract: Described herein are fluid complex coacervates that produce solid adhesives in situ. Oppositely charged polyelectrolytes were designed to form fluid adhesive complex coacervates at ionic strengths higher than the ionic strength of the application site, but an insoluble adhesive solid or gel at the application site. When the fluid, high ionic strength adhesive complex coacervates are introduced into the lower ionic strength application site, the fluid complex coacervate is converted to a an adhesive solid or gel as the salt concentration in the complex coacervate equilibrates to the application site salt concentration. In one embodiment, the fluid complex coacervates are designed to solidify in situ at physiological ionic strength and have numerous medical applications. In other aspects, the fluid complex coacervates can be used in aqueous environment for non-medical applications.
Abstract: The present invention is directed to wet wipes and methods of making thereof. In one aspect, a wet wipe includes a multi-ply tissue impregnated with a wetting composition. The multi-ply tissue includes papermaking fibers, is substantially free of synthetic fibers, and has an absorbent capacity of at least about 8 grams of the wetting composition per gram of the dry multi-ply tissue (g/g) as measured in accordance with American Society for Testing and Materials International (ASTM International) standard D4250. A single ply of the multi-ply tissue has a basis weight of at least 8 pounds per 3,000 square foot ream (lb/rm).
Type:
Grant
Filed:
September 22, 2015
Date of Patent:
July 16, 2019
Assignee:
GPCP IP Holdings LLC
Inventors:
Samuel C. Baer, Steven L. Cavadeas, Kip K. Decker, Donald H. Wolfe
Abstract: A biocompatible, electrically conductive biomaterial capable of earn carrying the electrical potential of a cardiac impulse and comprising (1) a conductive polymer such as polyaniline, polypyrrole or polythiophene, and (ii) a biocompatible component such as a polysaccharide, a protein, or a polypeptide, in particular chitosan or gelatin, is described. The material can take the form of a hydrogel, membrane, sheet or mesh. It can be used to restore or improve electrical impulse propagation across damaged tissue or scar region of the myocardium, in particular in the ti treatment of myocardial infarction and arrhythmia.
Abstract: The present invention provides antifungal compositions, and in particular, to antifungal formulations comprising a combination of an antifungal active agent and an AOX inhibitor for use in treating fungal infections in plants and animals.
Type:
Grant
Filed:
January 23, 2015
Date of Patent:
July 2, 2019
Inventors:
Anthony Moore, Luke Young, Benjamin May
Abstract: Compositions including a discontinuous oil phase homogeneously dispersed in a continuous water phase, the oil phase containing a sunscreen agent that includes a polymer composition containing a linear, ultraviolet radiation absorbing polyether, the linear, ultraviolet radiation absorbing polyether including a chemically bound UV-chromophore; and an oil-in water emulsifier component including an anionic oil-in-water emulsifier in an amount such that the composition includes about 0.5 percent by weight to about 3 percent by weight of the anionic oil-in-water emulsifier.
Abstract: The invention provides articles of 3D printed biomaterials with retained physical properties and biological activity and methods of using the articles. Furthermore, the invention provides manufacturing conditions to generate 3D printed biomaterials with highly preserved biological activity.
Type:
Grant
Filed:
December 31, 2015
Date of Patent:
May 7, 2019
Assignee:
Bacterin International, Inc.
Inventors:
Daniel Cox, Dominic Denty, Helena Lovick